Greenbrook

Greenbrook is a specialized provider of innovative depression treatments including NeuroStar TMS Therapy and SPRAVATO, an FDA-approved esketamine nasal spray. The clinic focuses on non-invasive and non-drug approaches to alleviate symptoms of depression, catering to individuals who may not have found relief through traditional medications or therapy.

With a commitment to patient care, Greenbrook's treatments are designed to fit seamlessly into existing care plans and are covered by most major insurance providers, including Medicare and Medicaid. The organization aims to support those suffering from depression by providing effective treatment options and a compassionate care environment.

Generated from the website